E. Burtseva, A. D. Panova, L. Kolobukhina, A. V. Ignatjeva, E. Kirillova, N. V. Breslav, S. Trushakova, E. Mukasheva, E. L. Feodoritova, K. Krasnoslobodtsev, L. N. Merkulova, I. N. Khlopova, L. Kisteneva, I. Kruzhkova, Yu. S. Levochkina, Anastasia S. Krepkaia, Aleksandra G. Rosatkevich, A. Komissarov, Svetlana B. Yatsishina, Andrey A. Pochtovyi, D. D. Kustova, V. V. Gushchin, M. Bazarova, S. Smetanina, N. Tsvetkova
{"title":"EPIDEMIC SEASON 2021-2022. FREQUENCY OF CO-INFECTION BY \nRESPIRATORY VIRAL PATHOGENS","authors":"E. Burtseva, A. D. Panova, L. Kolobukhina, A. V. Ignatjeva, E. Kirillova, N. V. Breslav, S. Trushakova, E. Mukasheva, E. L. Feodoritova, K. Krasnoslobodtsev, L. N. Merkulova, I. N. Khlopova, L. Kisteneva, I. Kruzhkova, Yu. S. Levochkina, Anastasia S. Krepkaia, Aleksandra G. Rosatkevich, A. Komissarov, Svetlana B. Yatsishina, Andrey A. Pochtovyi, D. D. Kustova, V. V. Gushchin, M. Bazarova, S. Smetanina, N. Tsvetkova","doi":"10.17816/eid321873","DOIUrl":null,"url":null,"abstract":"Introduction. The main purpose of this work was to determine the characteristics of the circulation of various viral respiratory pathogens during the epidemic season 2021-2022, as well as the frequency of co-infection against the background of SARS-CoV-2 and influenza. \nMaterials and methods. The article uses methods of \"traditional\" and \"hospital\" epidemiological surveillance for acute respiratory viral infections. \nResults and discussion. The epidemic season of 2021-2022 was characterized by the early activity of the influenza A(H3N2) virus, as well as the appearance and rapid spread of a new variant of SARS-CoV-2 (omicron). The dependence on the share of different respiratory pathogens during the epidemic season 2021-2022 was clearly traced: the dominant role belonged to SARS-CoV-2 (18.8%), then to influenza viruses (10.6%) and, finally, to pathogens of other acute respiratory viral infections (0.4%-3.7%). With respect to influenza A(H3N2) and B viruses, heterogeneity of their populations and drift-variability in relation to vaccine strains were noted. The frequency of co-infection with various respiratory pathogens was low: according to \"traditional surveillance\" - no more than 0.1%, \"hospital surveillance\" no more than 9.2%. The rationale for updating the composition of influenza vaccines for the countries of the Northern Hemisphere for 2022-2023 season was given.","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":"25 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of infectious diseases and epidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/eid321873","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction. The main purpose of this work was to determine the characteristics of the circulation of various viral respiratory pathogens during the epidemic season 2021-2022, as well as the frequency of co-infection against the background of SARS-CoV-2 and influenza.
Materials and methods. The article uses methods of "traditional" and "hospital" epidemiological surveillance for acute respiratory viral infections.
Results and discussion. The epidemic season of 2021-2022 was characterized by the early activity of the influenza A(H3N2) virus, as well as the appearance and rapid spread of a new variant of SARS-CoV-2 (omicron). The dependence on the share of different respiratory pathogens during the epidemic season 2021-2022 was clearly traced: the dominant role belonged to SARS-CoV-2 (18.8%), then to influenza viruses (10.6%) and, finally, to pathogens of other acute respiratory viral infections (0.4%-3.7%). With respect to influenza A(H3N2) and B viruses, heterogeneity of their populations and drift-variability in relation to vaccine strains were noted. The frequency of co-infection with various respiratory pathogens was low: according to "traditional surveillance" - no more than 0.1%, "hospital surveillance" no more than 9.2%. The rationale for updating the composition of influenza vaccines for the countries of the Northern Hemisphere for 2022-2023 season was given.